Overfeeding Induced Fat-tissue Stimulation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorGerman Diabetes Center

About this trial

Type 2 diabetes is the most common metabolic disease worldwide, characterized by hyperglycemia, decreased whole body insulin sensitivity, and white adipose tissue (WAT) dysfunction. A key factor in its development is chronic overnutrition, usually with a high-fat diet (HFD), leading to disturbances of glucose and lipid metabolism. However, the mechanism of short-term HFD-induced tissue-specific insulin resistance remains poorly understood. This project aims to further unravel the underlying mechanisms of short-term HFD overnutrition-mediated WAT insulin resistance. The model described here corresponds to a randomized, single- blinded parallel-grouped trial, consisting of two interventions: a macronutrient-balanced diet and or a hypercaloric diet over three weeks in order to investigate differences in interorgan fatty acid and glucose metabolism between the studied groups. Based on recent studies, the hypothesis is that 21-day hypercaloric HFD induces WAT insulin resistance via a diacylglycerol, novel protein kinase C-insulin receptor signaling model in both fasting and insulin-stimulated states.

Eligibility criteria

Qualifiers

Age between 18 and 40 years

BMI < 29 kg/m2

Sport inactive (<1x /week)

Capacity to consent

Disqualifiers

Diabetes mellitus disease

Acute coronary heart syndrome (myocardial infarction, unstable angina pectoris, stroke or transient ischemic attack in the last 3 months before study participation)

Acute infectious disease

Taking blood glucose-lowering drugs

Trial design

Treatments tested in this trial

  • High-fat overnutrition
  • Normocaloric macronutrient-balanced nutrition

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators

German Diabetes Center

Lead sponsor

Yale University

Collaborator